BioNTech SE - ADR logo

BNTX

BioNTech SE - ADR

$149.22

Earnings Summary

Revenue
$6374.6Mn
Net Profits
$3698.8Mn
Net Profit Margins
58.02%
PE Ratio
3.49

Highlights

Revenue:

BioNTech SE - ADR’s revenue jumped 211.2% since last year same period to $6374.6Mn in the Q1 2022. On a quarterly growth basis, BioNTech SE - ADR has generated 15.22% jump in its revenue since last 3-months.

Net Profits:

BioNTech SE - ADR’s net profit jumped 227.88% since last year same period to $3698.8Mn in the Q1 2022. On a quarterly growth basis, BioNTech SE - ADR has generated 16.82% jump in its net profits since last 3-months.

Net Profit Margins:

BioNTech SE - ADR’s net profit margin jumped 5.36% since last year same period to 58.02% in the Q1 2022. On a quarterly growth basis, BioNTech SE - ADR has generated 1.39% jump in its net profit margins since last 3-months.

PE Ratio:

BioNTech SE - ADR’s price-to-earnings ratio after this Q1 2022 earnings stands at 3.49.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the BioNTech SE - ADR post its latest quarter earnings

EPS Estimate Current Quarter
7.27
EPS Estimate Current Year
7.27

Highlights

EPS Estimate Current Quarter:

BioNTech SE - ADR’s earning per share (EPS) estimates for the current quarter stand at 7.27 - a -21.32% fall from last quarter’s estimates.

EPS Estimate Current Year:

BioNTech SE - ADR’s earning per share (EPS) estimates for the current year stand at 7.27.

Key Ratios

Key ratios of the BioNTech SE - ADR post its Q1 2022 earnings

Earning Per Share (EPS)
14.24
Return on Assets (ROA)
0.63
Return on Equity (ROE)
1.05
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

BioNTech SE - ADR’s earning per share (EPS) jumped 224.37% since last year same period to 14.24 in the Q1 2022. This indicates that the BioNTech SE - ADR has generated 224.37% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. BioNTech SE - ADR’s return on assets (ROA) stands at 0.63.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. BioNTech SE - ADR’s return on equity (ROE) stands at 1.05.

Dividend Per Share (DPS):

BioNTech SE - ADR declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-03-31
9.24
14.24
54.11%

Company Information

BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.

Organisation
BioNTech SE - ADR
Headquarters
Mainz, Rheinland Pfalz, Germany
Employees
2.02K
Industry
Health Technology